Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.
Objectively Quantified Physical Activity in Persons with Multiple Sclerosis.
Impairment and disability in 20 CIDP patients according to disease activity status.
Clinical and Magnetic Resonance Imaging (MRI) Distinctions Between Tumefactive Demyelination and Brain Tumors in Children.
Childhood Guillain-Barré syndrome subtypes in northern India.
Inhibitors of myelination: ECM changes, CSPGs and PTPs.
New diagnostic criteria for multiple sclerosis in patients with clinically isolated syndromes: Some questions could be raised during clinical practice.
A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy.
Social Cognitive Predictors of Physical Activity in Relapsing-Remitting Multiple Sclerosis.
Erratum to: Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
Disease-modifying agents in multiple sclerosis.
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity.
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
Resistant Strains of Enterotoxigenic Staphylococcus aureus; Unknown Risk for Multiple Sclerosis Exacerbation.
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Literature Commentary.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Accuracy and Reproducibility of a Quantitative Magnetic Resonance Imaging Method for Concurrent Measurements of Tissue Relaxation Times and Proton Density.
Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis.
Pages
« first
‹ previous
…
607
608
609
610
611
612
613
614
615
…
next ›
last »